Teva adopts biotech ethos as it leans into innovative drug development, exec says

Amid a reorganization campaign that’s breathed new life into hybrid generic and innovative medicines player Teva, the company is leaning into novel medicines and formulations more than ever and adopting a biotech mindset as it pushes a range of assets through the clinic.